Ortoma Past Earnings Performance
Past criteria checks 3/6
Ortoma's earnings have been declining at an average annual rate of -0.08%, while the Medical Equipment industry saw earnings growing at 30% annually. Revenues have been growing at an average rate of 37.6% per year. Ortoma's return on equity is 3.4%, and it has net margins of 6.8%.
Key information
-0.079%
Earnings growth rate
14.03%
EPS growth rate
| Medical Equipment Industry Growth | 6.16% |
| Revenue growth rate | 37.56% |
| Return on equity | 3.41% |
| Net Margin | 6.79% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Investors Will Want Ortoma's (STO:ORT B) Growth In ROCE To Persist
Oct 02
Ortoma (STO:ORT B) Might Have The Makings Of A Multi-Bagger
Jun 26Ortoma (STO:ORT B) Is In A Good Position To Deliver On Growth Plans
Mar 17Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Nov 13Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Oct 25Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price
Sep 20We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate
Jun 03We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth
Dec 09Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans
Aug 17Revenue & Expenses Breakdown
How Ortoma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 90 | 6 | 24 | 0 |
| 31 Mar 25 | 93 | 10 | 24 | 0 |
| 31 Dec 24 | 61 | -12 | 22 | 0 |
| 30 Sep 24 | 64 | -30 | 13 | 0 |
| 30 Jun 24 | 62 | -31 | 15 | 0 |
| 31 Mar 24 | 64 | -23 | 13 | 0 |
| 31 Dec 23 | 62 | -22 | 12 | 0 |
| 30 Sep 23 | 48 | 1 | 10 | 0 |
| 30 Jun 23 | 44 | 0 | 7 | 0 |
| 31 Mar 23 | 25 | -17 | 7 | 0 |
| 31 Dec 22 | 23 | -16 | 6 | 0 |
| 30 Sep 22 | 21 | -11 | 6 | 0 |
| 30 Jun 22 | 19 | -12 | 8 | 0 |
| 31 Mar 22 | 20 | -11 | 7 | 0 |
| 31 Dec 21 | 20 | -11 | 6 | 0 |
| 30 Sep 21 | 20 | -12 | 5 | 0 |
| 30 Jun 21 | 20 | -11 | 3 | 0 |
| 31 Mar 21 | 20 | -9 | 2 | 0 |
| 31 Dec 20 | 18 | -9 | 2 | 0 |
| 30 Sep 20 | 17 | -9 | 2 | 0 |
| 30 Jun 20 | 16 | -9 | 2 | 0 |
| 31 Mar 20 | 14 | -10 | 2 | 0 |
| 31 Dec 19 | 12 | -10 | 2 | 0 |
| 30 Sep 19 | 11 | -8 | 1 | 0 |
| 30 Jun 19 | 11 | -7 | 1 | 0 |
| 31 Mar 19 | 11 | -7 | 1 | 0 |
| 31 Dec 18 | 12 | -8 | 2 | 0 |
| 30 Sep 18 | 14 | -8 | 2 | 0 |
| 30 Jun 18 | 16 | -8 | 2 | 0 |
| 31 Mar 18 | 16 | -8 | 2 | 0 |
| 31 Dec 17 | 17 | -7 | 2 | 0 |
| 30 Sep 17 | 17 | -7 | 2 | 0 |
| 30 Jun 17 | 16 | -6 | 2 | 0 |
| 31 Mar 17 | 16 | -5 | 3 | 0 |
| 31 Dec 16 | 15 | -5 | 2 | 0 |
| 30 Sep 16 | 13 | -4 | 2 | 0 |
| 30 Jun 16 | 11 | -4 | 2 | 0 |
| 31 Mar 16 | 10 | -4 | 2 | 0 |
| 31 Dec 15 | 9 | -4 | 2 | 0 |
| 30 Sep 15 | 9 | -4 | 2 | 0 |
| 30 Jun 15 | 9 | -5 | 3 | 0 |
| 31 Mar 15 | 9 | -5 | 3 | 0 |
| 31 Dec 14 | 8 | -4 | 3 | 0 |
Quality Earnings: ORT B has high quality earnings.
Growing Profit Margin: ORT B became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ORT B has become profitable over the past 5 years, growing earnings by -0.08% per year.
Accelerating Growth: ORT B has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ORT B has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-16.2%).
Return on Equity
High ROE: ORT B's Return on Equity (3.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 10:14 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ortoma AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Klas Palin | DNB Carnegie Commissioned Research |
| Mats Hyttinge | Redeye |